Cover Image

Treatment of Crohn’s disease with colony-stimulating factors: An overview

Luisa Guidi1, Giammarco Mocci1, Manuela Marzo1, Sergio Rutella21Department of Internal Medicine, Operative Unit of Gastroenterology, and 2Department of Hematology, Laboratory of Immunology, Università Cattolica del Sacro Cuore, Rome, ItalyAbstract: Current treatments for Crohn’s...

Full description

Saved in:

Bibliographic Details
Main Authors:	Luisa Guidi (Author), Giammarco Mocci (Author), Manuela Marzo (Author), Sergio Rutella (Author)
Format:	Book
Published:	Dove Medical Press, 2008-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Profile of infliximab in the treatment of pediatric Crohn’s disease
by: Kierus J, et al.
Published: (2015)

Clinical utility of ustekinumab in Crohn’s disease
by: Kotze PG, et al.
Published: (2018)

Ustekinumab in treatment of Crohn’s disease: design, development, and potential place in therapy
by: Deepak P, et al.
Published: (2016)

Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview
by: Svob Strac D, et al.
Published: (2021)

Burden of Crohn’s disease: economics and quality of life aspects in Italy
by: Benedini V, et al.
Published: (2012)

An evidence-based review of natalizumab therapy in the management of Crohn’s disease
by: Raja GR Edula, et al.
Published: (2009)

Potential Application of Granulocyte-colony Stimulating Factor in the Treatment of Neurological Diseases
by: Wang-Tso Lee
Published: (2013)

Identification of Targets for Subsequent Treatment of Crohn’s Disease Patients After Failure of Anti-TNF Therapy
by: Yao Y, et al.
Published: (2023)

Multiple Lesions at Different Stages of Pyoderma Gangrenosum in a Crohn’s Disease Patient
by: Zhang H, et al.
Published: (2022)

Prediction of the Short-Term Effectiveness of Ustekinumab in Patients with Moderate to Severe Crohn’s Disease
by: Su T, et al.
Published: (2024)

Clinical Features of Crohn’s Disease Stratified by Age at Diagnosis According to Montreal Classification
by: Xiang J, et al.
Published: (2023)

Granulocyte colony-stimulating factor and leukemogenesis
by: Lorena Lobo de Figueiredo, et al.
Published: (2004)

Clinical Evaluation of Risankizumab in the Treatment of Adults with Moderately to Severely Active Crohn’s Disease: Patient Selection and Reported Outcomes
by: Horst S, et al.
Published: (2023)

Identification of Key Disulfidptosis-Related Genes and Their Association with Gene Expression Subtypes in Crohn’s Disease
by: Fu M, et al.
Published: (2024)

Therapeutic potential of macrophage colony-stimulating factor in chronic liver disease
by: Sahar Keshvari, et al.
Published: (2022)

Granulocyte Colony-Stimulating Factor in Amniotic Fluid
by: B. Denise Raynor, et al.
Published: (1995)

The Identification of a Novel Thiopurine S-Methyltransferase Allele, TPMT*45, in Korean Patient with Crohn’s Disease
by: Ha C, et al.
Published: (2020)

Antibiotic Therapy for Active Crohn's Disease Targeting Pathogens: An Overview and Update
by: Gaetano Iaquinto, et al.
Published: (2024)

Granulocyte Colony-Stimulating Factor Treatment Before Radiotherapy Protects Against Radiation-Induced Liver Disease in Mice
by: Isalira Peroba Rezende Ramos, et al.
Published: (2021)

Predicting Mucosal Healing in Crohn’s Disease: A Nomogram Model Developed from a Retrospective Cohort
by: Tang N, et al.
Published: (2022)

Prealbumin and Retinol-Binding Protein 4: The Promising Inflammatory Biomarkers for Identifying Endoscopic Remission in Crohn’s Disease
by: Chen R, et al.
Published: (2021)

Crohn's disease - diagnosis and treatment
by: Patrycja Ręba
Published: (2021)

A rare occurrence of myocarditis with acute heart failure as an extraintestinal manifestation of Crohn’s disease in a young male
by: M. F. W. Ferose, et al.
Published: (2024)

Extraintestinal Crohn's disease (metastatic Crohn's disease)
by: Michał Rożalski
Published: (2014)

Granulocyte colony-stimulating factor and reproductive medicine: A review
by: Marcelo Borges Cavalcante, et al.
Published: (2015)

Advances in the surgical treatment of Crohn's disease
by: Antonio Luberto, et al.
Published: (2022)

Smoking: etiologic factor for Crohn's disease
by: Moniki de Oliveira Barbosa Campos, Tamires Barradas Cavalcante
Published: (2020)

Construction of ceRNA Network to Reveal Potential Biomarkers in Crohn’s Disease and Validation in a TNBS Induced Mice Model
by: Ye C, et al.
Published: (2021)

Successful treatment with granulocyte-colony stimulating factor for ritodrine-induced neutropenia in a twin pregnancy
by: Chen-Yu Wang, et al.
Published: (2016)

Vulvoperineal Crohn's disease responsive to metronidazole
by: Aristóteles Rosmaninho, et al.
Published: (2013)

FPR1, as a Potential Biomarker of Diagnosis and Infliximab Therapy Responses for Crohn’s Disease, is Related to Disease Activity, Inflammation and Macrophage Polarization
by: Ye C, et al.
Published: (2024)

The Role of Combined Treatment of Granulocyte Colony-stimulating Factor and Oestrogen in Treatment of Thin Endometrium: A Rat Model
by: Inci Kahyaoglu, et al.
Published: (2024)

Use of granulocyte colony-stimulating factor in patients with chemotherapy-induced neutropaenia
by: Lucky L. Shokane, et al.
Published: (2023)

Contrasting Immunopathogenic and Therapeutic Roles of Granulocyte Colony-Stimulating Factor in Cancer
by: Annette J. Theron, et al.
Published: (2020)

Crohn's Disease
Published: (2012)

Crohn disease
by: Stephen A. Geller, et al.
Published: (2015)

Successful treatment of metastatic Crohn disease with dapsone
by: Yu-Hao Chen, et al.
Published: (2021)

Change in the treatment strategy for pediatric Crohn's disease
by: Mi Jin Kim, et al.
Published: (2010)

Deep-Learning, Radiomics and Clinic Based Fusion Models for Predicting Response to Infliximab in Crohn’s Disease Patients: A Multicentre, Retrospective Study
by: Cai W, et al.
Published: (2024)

Granulocyte colony-stimulating factor (G-CSF) mediates bone resorption in periodontitis
by: Hui Yu, et al.
Published: (2021)